Profund Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Sell |
42,002
-619
| -1% | -$26.7K | 0.07% | 200 |
|
|
2025
Q1 | $1.47M | Sell |
42,621
-6,470
| -13% | -$224K | 0.06% | 221 |
|
|
2024
Q4 | $1.35M | Buy |
49,091
+125
| +0.3% | +$3.43K | 0.05% | 250 |
|
|
2024
Q3 | $1.25M | Sell |
48,966
-2,063
| -4% | -$52.5K | 0.05% | 277 |
|
|
2024
Q2 | $1.29M | Buy |
51,029
+555
| +1% | +$14.1K | 0.05% | 254 |
|
|
2024
Q1 | $1.56M | Buy |
50,474
+4,127
| +9% | +$128K | 0.06% | 214 |
|
|
2023
Q4 | $1.87M | Sell |
46,347
-7,522
| -14% | -$304K | 0.08% | 187 |
|
|
2023
Q3 | $1.42M | Sell |
53,869
-40,596
| -43% | -$1.07M | 0.08% | 201 |
|
|
2023
Q2 | $1.62M | Buy |
94,465
+43,692
| +86% | +$752K | 0.09% | 185 |
|
|
2023
Q1 | $842K | Buy |
+50,773
| New | +$842K | 0.05% | 346 |
|
|
2022
Q3 | – | Sell |
-14,549
| Closed | -$132K | – | 928 |
|
|
2022
Q2 | $132K | Sell |
14,549
-1,974
| -12% | -$17.9K | 0.01% | 957 |
|
|
2022
Q1 | $168K | Sell |
16,523
-1,839
| -10% | -$18.7K | 0.01% | 1292 |
|
|
2021
Q4 | $306K | Sell |
18,362
-2,517
| -12% | -$41.9K | 0.01% | 968 |
|
|
2021
Q3 | $979K | Buy |
+20,879
| New | +$979K | 0.03% | 363 |
|